The proportion of “national blood” in domestic blood-derived products would be ratcheted up over the next few years to reduce dependence on foreign sources and reinforce Taiwan’s medical resilience, the Food and Drug Administration (FDA) said on Saturday.
The Ministry of Health and Welfare has announced a development program, saying that domestic plasma demand would rise to 170 tonnes next year from 140 tonnes, with growing demand for immunoglobulins, albumin and factor VIII.
Although Taiwan currently has sufficient blood supply, it has long relied on imports for blood-derived products, it said.
Photo: Chung Li-hua, Taipei Times
As foreign blood products carry the risks of contracting foreign infectious diseases and running short of supply during emergencies, securing “national blood” — blood donated by Taiwanese and its derived products — for domestic use is crucial, the ministry said.
FDA Deputy Director-General Wang Te-yuan (王德原) said the ministry’s data on projected demand were derived from reported usage under the National Health Insurance program and the number of blood products’ lot releases.
Increasing the proportion of domestic blood products is significant, as import shortages could occur during wars or pandemics due to other countries’ export controls, he said.
As Taiwan has yet to have a blood product manufacturer, the government has since 2007 allowed the Taiwan Blood Services Foundation to commission CSL Behring to produce national blood-based products in Australia, Wang said.
Of the total of 71 licenses approved for blood products circulated in Taiwan, two immunoglobulin licenses and an albumin license are for national blood-derived products, while the others are for those manufactured based on non-national blood, he said.
Currently, immunoglobulins derived from national blood plasma account for only half of the domestic demand, while albumin contributes to a still lower proportion of less than 10 percent, Wang said.
Foreign plasma products might not be as efficacious as those based on national blood plasma due to epidemiological differences, he said, adding that boosting national blood-derived products is the key to solid medical resilience.
The FDA announced draft amendments to Blood Donors’ Health Standards (捐血者健康標準) on Oct. 24 last year, which would raise donor age eligibility to 70 and relax body weight limits, with expectations that more blood would be donated to increase the percentage of national blood-derived products, Wang said.
Taiwan Society of Blood Transfusion executive director Lo Shih-chi (羅仕錡) said that clinical indications of immunoglobulin continue to expand and its usage increases every year, making it one of the most important blood products for treating autoimmune diseases, such as thrombocytopenia and systemic lupus erythematosus.
Albumin and factor VIII usages have been relatively stable and are recommended for people with liver diseases and hemophilia, he added.
Taipei Blood Center planning division director-general Liu Chun-hung (劉俊宏) said each pack of donated blood can be separated into plasma and red blood cells.
Plasma extracted from national blood is estimated to be enough to meet next year’s extra 30 tonnes of plasma demand, as red blood cells are in higher demand while plasma is largely left in storage, he said.
‘DENIAL DEFENSE’: The US would increase its military presence with uncrewed ships, and submarines, while boosting defense in the Indo-Pacific, a Pete Hegseth memo said The US is reorienting its military strategy to focus primarily on deterring a potential Chinese invasion of Taiwan, a memo signed by US Secretary of Defense Pete Hegseth showed. The memo also called on Taiwan to increase its defense spending. The document, known as the “Interim National Defense Strategic Guidance,” was distributed this month and detailed the national defense plans of US President Donald Trump’s administration, an article in the Washington Post said on Saturday. It outlines how the US can prepare for a potential war with China and defend itself from threats in the “near abroad,” including Greenland and the Panama
The High Prosecutors’ Office yesterday withdrew an appeal against the acquittal of a former bank manager 22 years after his death, marking Taiwan’s first instance of prosecutors rendering posthumous justice to a wrongfully convicted defendant. Chu Ching-en (諸慶恩) — formerly a manager at the Taipei branch of BNP Paribas — was in 1999 accused by Weng Mao-chung (翁茂鍾), then-president of Chia Her Industrial Co, of forging a request for a fixed deposit of US$10 million by I-Hwa Industrial Co, a subsidiary of Chia Her, which was used as collateral. Chu was ruled not guilty in the first trial, but was found guilty
A wild live dugong was found in Taiwan for the first time in 88 years, after it was accidentally caught by a fisher’s net on Tuesday in Yilan County’s Fenniaolin (粉鳥林). This is the first sighting of the species in Taiwan since 1937, having already been considered “extinct” in the country and considered as “vulnerable” by the International Union for Conservation of Nature. A fisher surnamed Chen (陳) went to Fenniaolin to collect the fish in his netting, but instead caught a 3m long, 500kg dugong. The fisher released the animal back into the wild, not realizing it was an endangered species at
DEADLOCK: As the commission is unable to forum a quorum to review license renewal applications, the channel operators are not at fault and can air past their license date The National Communications Commission (NCC) yesterday said that the Public Television Service (PTS) and 36 other television and radio broadcasters could continue airing, despite the commission’s inability to meet a quorum to review their license renewal applications. The licenses of PTS and the other channels are set to expire between this month and June. The National Communications Commission Organization Act (國家通訊傳播委員會組織法) stipulates that the commission must meet the mandated quorum of four to hold a valid meeting. The seven-member commission currently has only three commissioners. “We have informed the channel operators of the progress we have made in reviewing their license renewal applications, and